Kotak Securities Recommends Buying Shares of Jubilant Ingrevia and Vishal Mega Mart
Stocks to buy: Kotak Sec recommends Jubilant Ingrevia, Vishal Mega Mart
business-standard
Image: business-standard
Kotak Securities has recommended buying shares of Vishal Mega Mart and Jubilant Ingrevia, highlighting their strong market positions and growth potential. Vishal Mega Mart is expected to achieve a fair value of ₹145, while Jubilant Ingrevia's fair value is estimated at ₹880, driven by robust contract-driven growth in specialty chemicals.
- 01Vishal Mega Mart's fair value is estimated at ₹145, with a strong expansion strategy and private label growth.
- 02The company operates 771 stores across 517 cities in India, focusing on middle and lower-middle income consumers.
- 03Jubilant Ingrevia's fair value is projected at ₹880, supported by a significant agrochemical contract worth $300 million.
- 04The specialty chemicals segment is expected to drive earnings growth for Jubilant Ingrevia, with a 31% year-on-year EBITDA increase anticipated.
- 05Both companies are positioned well for future growth, with strong revenue and earnings projections.
Advertisement
In-Article Ad
Kotak Securities, led by Shrikant Chouhan, has recommended buying shares of Vishal Mega Mart and Jubilant Ingrevia, citing their robust growth strategies and market positions. Vishal Mega Mart, a leading offline retailer in India, focuses on middle and lower-middle income consumers. The company operates 771 stores across 517 cities and aims for a fair value of ₹145. Its private label strategy contributed to 74.5% of revenue, with a 17% year-on-year revenue growth reported for Q3FY26. Meanwhile, Jubilant Ingrevia, a diversified chemicals player, is transitioning to high-margin specialty chemicals. It has secured a $300 million agrochemical contract, expected to significantly enhance earnings starting March 2026. The company's fair value is estimated at ₹880, with anticipated 31% year-on-year EBITDA growth due to a strong order pipeline and favorable market conditions.
Advertisement
In-Article Ad
The recommendations could influence investor decisions, potentially impacting stock prices and market dynamics for both companies.
Advertisement
In-Article Ad
Reader Poll
Do you think investing in retail and specialty chemicals is a good strategy right now?
Connecting to poll...
More about Kotak Securities
Read the original article
Visit the source for the complete story.